Erschienen in:
05.09.2023 | Editorial (by Invitation)
Editorial to: visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity
verfasst von:
Igor Kozak
Erschienen in:
Graefe's Archive for Clinical and Experimental Ophthalmology
|
Ausgabe 11/2023
Einloggen, um Zugang zu erhalten
Excerpt
The
Graefe’s Archives of Clinical and Experimental Ophthalmolmology is the journal that published one of the first scientific reports on visual field loss following tissue destructive treatment of premature children with retinopathy of prematurity (ROP) [
1]. The report has accelerated interest and research on visual field and peripheral vision development in ROP children. Most of the outcome data come from follow-up measurements years after retinal cryo- or laser therapy. The recent advent of anti-VEGF (vascular endothelial growth factor) intravitreal therapy in ROP has brought hope of tissue sparing treatment that addresses vascular pathobiology of the disease. Intravitreal anti-VEGF drug injection was reported to be effective for ROP treatment [
2] even though the disease recurrences following monotherapy are known and not infrequent. …